Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZHONGZHIPHARM

0.810
0.000
Volume:68.00K
Turnover:55.08K
Market Cap:699.52M
PE:6.59
High:0.810
Open:0.810
Low:0.810
Close:0.810
Loading ...
OverviewCompanyNewsFilings

Zhongzhi Pharmaceutical Holdings Ltd. Conducted Annual General Meeting

Reuters
·
13 May

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has Announced That It Will Be Increasing Its Dividend To CN¥0.05

Simply Wall St.
·
11 Apr

Zhongzhi Pharmaceutical Expects Profit to Plunge 45% in 2024

MT Newswires Live
·
17 Jan

Zhongzhi Pharmaceutical Sees Decrease in Net Profit of 45% for Year

THOMSON REUTERS
·
17 Jan

Zhongzhi Pharmaceutical - Expected Result Due to an Increase in Investment Costs Through Online Channels and Offline Advertising Expenses, Others

THOMSON REUTERS
·
17 Jan

Insider Buying: Zhongzhi Pharmaceutical Holdings Chairman Bought CN¥839k Of Shares

Simply Wall St.
·
11 Jan

The recent 10.0% gain must have brightened Top Key Executive Zhi Tian Lai's week, Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) most bullish insider

Simply Wall St.
·
28 Dec 2024

Zhongzhi Pharmaceutical Invests in US Biotech Firm to Advance Alzheimer's Treatment

MT Newswires Live
·
24 Dec 2024

Zhongzhi Pharmaceutical Holdings Plans to Unwind Contractual Agreements to Directly Hold Control Over Subsidiary

MT Newswires Live
·
06 Dec 2024

Analyst Rate

 
 
 
 

Corporate Actions

Ex-dividend Date
May 23, 2025 Dividend Per Share 0.05 HKD
Financial Report Announcement
Mar 26, 2025 Post Market
Financial Report Announcement
Aug 23, 2024 Post Market
Ex-dividend Date
May 24, 2024 Dividend Per Share 0.03 HKD
Financial Report Announcement
Mar 22, 2024

Dividend History

Ex-DateDividend
2016-05-170.035
2016-10-050.016
2017-05-240.01
2017-10-170.01875
2018-05-160.01709

Valuation Analysis

6.72
Current
8.20
Sector Average
33.90%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
6.72
Maximum
15.88
+1 STD
10.77
Minimum
4.38
-1 STD
5.63
Average
8.20

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.